Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2026
Improvement of Checklist for Briefing in Apheresis Therapy and Its Efficacy.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Suzuki Makiko, Hirano Hajime, Inoue Takahiro, Munakata Yu, Tokui Yoshie, Ito Ken, Horimoto Hiromi, Kumamaru Takashi, Tanaka Isao, Yamazaki Kaori, Matsumura Goki, Shimizu Yuko, Segawa Osamu, Nishimura Katsuji, Hanafusa Norio
Аннотация
PURPOSE: A checklist is an effective tool for ensuring patient safety. We have already been using a briefing checklist for hemodialysis. However, we did not have ones for apheresis therapy. From the experiences of incidents that occurred in February and March 2024. We decided to create a briefing checklist for apheresis therapy, especially for plasma exchange (PE) and double filtration plasmapheresis (DFPP).
METHODS: First, we made a briefing checklist specific to apheresis therapies, different from hemodialysis. Another incident occurred 6 months later, revealing that staff used the checklist in a manner different from the intended one. The fact prompted us to revise the apheresis therapy checklist, with items and the order of appearance similar to those of the hemodialysis checklist. We also provided detailed explanations of apheresis therapy for clinical engineers unfamiliar with it. We have not experienced any incident since September 2024, when the revised procedures were implemented, until May 2025.
CONCLUSION: The briefing checklist provided benefits, including improved patient safety and education for clinical engineers unfamiliar with apheresis. the revision process further improved the checklist's efficiency.
METHODS: First, we made a briefing checklist specific to apheresis therapies, different from hemodialysis. Another incident occurred 6 months later, revealing that staff used the checklist in a manner different from the intended one. The fact prompted us to revise the apheresis therapy checklist, with items and the order of appearance similar to those of the hemodialysis checklist. We also provided detailed explanations of apheresis therapy for clinical engineers unfamiliar with it. We have not experienced any incident since September 2024, when the revised procedures were implemented, until May 2025.
CONCLUSION: The briefing checklist provided benefits, including improved patient safety and education for clinical engineers unfamiliar with apheresis. the revision process further improved the checklist's efficiency.